Evidence map›Paper›PMID 40142600›Full record

ReviewJournal of clinical medicine2025

Catheter Ablation of Atrial Fibrillation: Technique and Future Perspectives.

Francesco Peruzza, Andrea Candelora, Carlo Angheben, Massimiliano Maines, Mauro Laurente, Domenico Catanzariti, Maurizio Del Greco, Antonio Madaffari

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesco PeruzzaDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.ORCID 0000-0002-5715-7864
Andrea CandeloraDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.
Carlo AnghebenDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.
Massimiliano MainesDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.ORCID 0000-0002-2576-1653
Mauro LaurenteDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.
Domenico CatanzaritiDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.
Maurizio Del GrecoDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.ORCID 0000-0002-2728-7844
Antonio MadaffariDepartment of Cardiology, Santa Maria del Carmine Hospital, Corso Verona 4, 38068 Rovereto, Italy.ORCID 0000-0001-8364-3279

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation is the most common sustained cardiac arrhythmia with a significant impact on quality of life in terms of symptoms and reduction of functional status. Also, it is associated with an increased risk of mortality, stroke, and peripheral embolism. Catheter ablation for atrial fibrillation has become a well-established treatment, improving arrhythmia outcomes without increasing the risk of serious adverse events compared to antiarrhythmic drug therapy. The field has undergone significant advancements in recent years, yet pulmonary vein isolation continues to be the cornerstone of any atrial fibrillation ablation procedure. The purpose of this review is to provide an overview of the current techniques, emerging technologies, and future directions.

Indexed as

atrial fibrillationcatheter ablationposterior wall isolationpulmonary vein isolationpulsed fieldvein of Marshall

Identifiers

PMID40142600
PMCPMC11943125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.